NasdaqCM - Delayed Quote USD

Nuwellis, Inc. (NUWE)

0.2890 +0.0369 (+14.64%)
At close: April 25 at 4:00 PM EDT
0.2800 -0.01 (-3.11%)
After hours: April 25 at 7:50 PM EDT
Loading Chart for NUWE
DELL
  • Previous Close 0.2521
  • Open 0.2962
  • Bid 0.3767 x 100
  • Ask 0.3000 x 100
  • Day's Range 0.2513 - 0.4000
  • 52 Week Range 0.2400 - 5.5200
  • Volume 9,819,681
  • Avg. Volume 998,617
  • Market Cap (intraday) 1.966M
  • Beta (5Y Monthly) 0.17
  • PE Ratio (TTM) --
  • EPS (TTM) -11.5200
  • Earnings Date May 7, 2024 - May 13, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 5.25

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

www.nuwellis.com

59

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NUWE

Performance Overview: NUWE

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NUWE
50.17%
S&P 500
5.84%

1-Year Return

NUWE
93.74%
S&P 500
22.03%

3-Year Return

NUWE
99.94%
S&P 500
20.77%

5-Year Return

NUWE
100.00%
S&P 500
72.46%

Compare To: NUWE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NUWE

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    1.97M

  • Enterprise Value

    -853.38k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.06

  • Price/Book (mrq)

    0.66

  • Enterprise Value/Revenue

    -0.10

  • Enterprise Value/EBITDA

    0.05

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -227.99%

  • Return on Assets (ttm)

    -63.98%

  • Return on Equity (ttm)

    -259.62%

  • Revenue (ttm)

    8.86M

  • Net Income Avi to Common (ttm)

    -22.63M

  • Diluted EPS (ttm)

    -11.5200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.8M

  • Total Debt/Equity (mrq)

    23.67%

  • Levered Free Cash Flow (ttm)

    -13.87M

Research Analysis: NUWE

Analyst Price Targets

1.50
5.25 Average
0.2890 Current
9.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: NUWE

Fair Value

0.2890 Current
 

Dividend Score

0 Low
NUWE
Sector Avg.
100 High
 

Hiring Score

0 Low
NUWE
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
NUWE
Sector Avg.
100 High
 

People Also Watch